查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942546

無細胞DNA（cfDNA）血液採集管全球市場報告（2026年）

Cell-Free DNA (cfDNA) Blood Collection Tube Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，無細胞DNA（cfDNA）血液採集管市場發展迅速，預計將從2025年的13.3億美元成長到2026年的15.1億美元，複合年成長率（CAGR）為13.6%。過去幾年的成長可歸因於多種因素，例如產前檢測需求的增加、癌症診斷的普及、cfDNA在研究中的應用、檢查室自動化程度的提高以及診斷中心的擴張。

無細胞DNA（cfDNA）血液採集管市場預計在未來幾年將快速成長，到2030年將達到24.9億美元，複合年成長率（CAGR）為13.3%。預測期內的成長要素包括血液保存方案的創新、與人工智慧診斷技術的融合、液態生物檢體市場的擴張、臨床試驗的增加以及新興市場需求的成長。預測期內的關鍵趨勢包括改進的樣本保存技術、與液態生物檢體平台的融合、標準化的血液採集通訊協定、自動化樣本處理以及高穩定性採血管設計。

預計未來幾年，呼吸系統疾病的日益普遍將推動無細胞DNA（cfDNA）採集管市場的成長。呼吸系統疾病是指影響肺部和其他呼吸系統的疾病，這些疾病會使正常呼吸困難，阻礙氧氣輸送到血液和二氧化碳排放體外。呼吸系統疾病發生率的上升主要是由於空氣污染，空氣污染會刺激呼吸道，降低肺功能，並增加氣喘、支氣管炎和慢性阻塞性肺病切片檢查的需求。例如，根據美國政府機構疾病管制與預防中心 (CDC) 2024 年 12 月的報告，2024 年 10 月 1 日至 11 月 30 日期間，因呼吸道融合細胞病毒(RSV) 住院的人數估計在 17,000 至 34,000 人之間。因此，呼吸道疾病發生率的上升正在推動 cfDNA 血液採集管的需求。

預計未來癌症發生率的上升將推動無細胞DNA（cfDNA）採集管市場的成長。癌症病例的增加與不良飲食、吸菸和缺乏運動等生活方式因素密切相關。 cfDNA採集管擴大用於癌症治療中的液態生物檢體，透過簡單的血液檢測即可檢測腫瘤特異性基因突變、監測疾病進展、評估治療效果並識別抗藥性突變。這種方法減少了侵入性組織切片檢查的需求。例如，根據美國政府機構國家癌症研究所2024年5月發布的預測，美國癌症倖存者人數預計將從2022年的1810萬人增加到2040年的26​​00萬人。因此，癌症發生率的上升正在推動對cfDNA採集管日益成長的需求。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球無細胞DNA（cfDNA）採血管市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 改良的樣品保存技術
    • 與液態生物檢體平台整合
    • 標準化的採血通訊協定
    • 自動化檢體處理
    • 高度穩定的管材設計

第5章 終端用戶產業市場分析

  • 診斷檢查室
  • 醫院
  • 基因診斷實驗室
  • 癌症研究中心
  • 研究與發展研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球無細胞DNA（cfDNA）血液採集管市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球無細胞DNA（cfDNA）血液採集管市場規模、比較及成長率分析
  • 全球無細胞DNA（cfDNA）血液採集管市場表現：規模與成長，2020-2025年
  • 全球無細胞DNA（cfDNA）血液採集管市場預測：規模和成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 5毫升，10毫升
  • 依樣本類型
  • 血漿、血清、全血
  • 透過使用
  • 體外診斷，科學研究
  • 最終用戶
  • 診斷實驗室、醫院或臨床中心、基因診斷實驗室、癌症研究中心、研發機構、常規診斷中心
  • 按類型細分：5毫升
  • 一次性試管、真空採血管、凝膠分離管
  • 按類型細分：10毫升
  • 雙抽採血管、大容量採血管、抗凝血處理採血管

第10章 區域與國家分析

  • 全球無細胞DNA（cfDNA）血液採集管市場：按地區、績效和預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球無細胞DNA（cfDNA）血液採集管市場：依國家/地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 無細胞DNA（cfDNA）血液採集管市場：競爭格局和市場佔有率，2024年
  • 無細胞DNA（cfDNA）血液採集管市場：公司估值矩陣
  • 無細胞DNA（cfDNA）血液採集管市場：公司概況
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
    • Becton Dickinson（BD）
    • Qiagen NV
    • SARSTEDT AG & Co. KG

第37章：其他領先和創新企業

  • Guangzhou Improve Medical Technology, Streck Inc., DiaCarta Inc., Zymo Research Corporation, Biomatrica Inc., PreAnalytiX GmbH, Beijing Cowin Bioscience Co.Ltd., Norgen Biotek Corporation, Nonacus Limited, Guangdong Ardent Biomed Co. Ltd, MagBio Genomics Inc., VanGenes, BEAVER, Hebei Xinle Science & Technology Co. Ltd., Nasmed Diagnostics Pvt. Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 無細胞DNA（cfDNA）血液採集管市場展望（2030）：提供新機會的國家
  • 無細胞DNA（cfDNA）血液採集管市場2030：新興細分市場機會
  • 無細胞DNA（cfDNA）血液採集管市場2030年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MCFDC02_G26Q1

A cell-free DNA (cfDNA) blood collection tube is a specialized device designed to collect, stabilize, and transport blood samples for cfDNA analysis. It contains preservatives that protect nucleic acids from degradation and minimize the release of genomic DNA from white blood cells. These tubes support accurate and reliable results in downstream applications such as liquid biopsy, prenatal testing, and cancer diagnostics.

The primary types in the cell-free DNA (cfDNA) blood collection tube market are 5 mL and 10 mL. The 5 mL cfDNA blood collection tube is a smaller-volume option commonly used for individual or routine sample collection. Sample types include plasma, serum, and whole blood. Applications cover in vitro diagnostics and scientific research. Key end-users include diagnostic laboratories, hospitals and clinical centers, genetic diagnostic labs, cancer research centers, research and development institutions, and conventional diagnostic facilities.

Tariffs are impacting the cfDNA blood collection tube market by increasing the cost of imported tubes and reagents, particularly in regions such as europe and asia-pacific. Hospitals, diagnostic labs, and research institutions are most affected. However, tariffs encourage development of locally manufactured tubes with improved preservation features, which may reduce dependency on imports and promote market growth.

The cell-free dna (cfdna) blood collection tube market research report is one of a series of new reports from The Business Research Company that provides cell-free dna (cfdna) blood collection tube market statistics, including cell-free dna (cfdna) blood collection tube industry global market size, regional shares, competitors with a cell-free dna (cfdna) blood collection tube market share, detailed cell-free dna (cfdna) blood collection tube market segments, market trends and opportunities, and any further data you may need to thrive in the cell-free dna (cfdna) blood collection tube industry. This cell-free dna (cfdna) blood collection tube market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell-free dna (cfdna) blood collection tube market size has grown rapidly in recent years. It will grow from $1.33 billion in 2025 to $1.51 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increasing demand for prenatal testing, growing cancer diagnostics, adoption of cfDNA in research, rising laboratory automation, expansion of diagnostic centers.

The cell-free dna (cfdna) blood collection tube market size is expected to see rapid growth in the next few years. It will grow to $2.49 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to innovation in blood tube preservatives, integration with AI diagnostics, growing liquid biopsy market, expansion of clinical trials, rising demand in emerging markets. Major trends in the forecast period include enhanced sample preservation, integration with liquid biopsy platforms, standardized blood collection protocols, automation in sample processing, high-stability tube designs.

The rising prevalence of respiratory disorders is expected to drive the growth of the cell-free DNA (cfDNA) blood collection tube market in the coming years. Respiratory disorders are conditions that impact the lungs and other parts of the respiratory system, making it difficult to breathe properly and affecting the delivery of oxygen to the blood or removal of carbon dioxide from the body. The growing prevalence of respiratory disorders is largely attributed to air pollution, which irritates the airways, decreases lung function, and heightens the risk of conditions such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). Cell-free DNA (cfDNA) blood collection tubes play a crucial role in managing respiratory disorders by detecting genetic mutations, tracking disease progression, and assessing treatment effectiveness with a simple blood test, reducing the need for invasive lung biopsies. For instance, in December 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that between October 1 and November 30, 2024, respiratory syncytial virus (RSV) led to an estimated 17,000 to 34,000 hospitalizations. Thus, the increasing occurrence of respiratory disorders is fueling the demand for cfDNA blood collection tubes.

The rising incidence of cancer is expected to drive growth in the cell-free DNA (cfDNA) blood collection tube market in the future. The growing number of cancer cases is linked to lifestyle factors such as poor diet, smoking, and lack of physical activity. cfDNA blood collection tubes are increasingly used in cancer care for liquid biopsies, which allow for the detection of tumor-specific genetic mutations, monitoring of disease progression, evaluation of treatment responses, and identification of resistance mutations through a simple blood test. This method reduces the need for invasive tissue biopsies. For example, in May 2024, the National Cancer Institute, a U.S.-based government agency, projected that the number of cancer survivors in the U.S. would rise to 26 million by 2040, up from 18.1 million in 2022. Therefore, the growing incidence of cancer is driving the demand for cfDNA blood collection tubes.

Key companies operating in the cfDNA blood collection tube market are focusing on automating cfDNA extraction to improve workflow efficiency. Automation of cfDNA extraction involves the use of advanced robotic systems and standardized procedures to isolate cell-free DNA from blood samples with minimal manual intervention, enhancing efficiency, accuracy, and consistency while reducing turnaround times and human error. For example, in September 2023, Yourgene Health plc, a molecular diagnostics company based in the UK, introduced the MagBench Automated DNA Extraction Instrument and Kit. This solution provides a fast, simple, and cost-effective bench-top robotic option optimized for cfDNA extraction in non-invasive prenatal testing (NIPT) workflows. The launch aims to enhance automation in NIPT workflows, delivering higher throughput, reproducibility, and reliability in cfDNA extraction while reducing hands-on time and operational expenses.

Major companies operating in the cell-free dna (cfdna) blood collection tube market are Roche Holding AG, Thermo Fisher Scientific Inc., Becton Dickinson (BD), Qiagen N.V., SARSTEDT AG & Co. KG, Guangzhou Improve Medical Technology, Streck Inc., DiaCarta Inc., Zymo Research Corporation, Biomatrica Inc., PreAnalytiX GmbH, Beijing Cowin Bioscience Co.Ltd., Norgen Biotek Corporation, Nonacus Limited, Guangdong Ardent Biomed Co. Ltd, MagBio Genomics Inc., VanGenes, BEAVER, Hebei Xinle Science & Technology Co. Ltd., Nasmed Diagnostics Pvt. Ltd.

North America was the largest region in the cell-free DNA (cfDNA) blood collection tube market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-free dna (cfdna) blood collection tube market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell-free dna (cfdna) blood collection tube market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell-free DNA (cfDNA) blood collection tube market consists of sales of plasma separation tubes, cryogenic storage systems, and plasma prep centrifugation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell-Free DNA (cfDNA) Blood Collection Tube Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cell-free dna (cfdna) blood collection tube market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell-free dna (cfdna) blood collection tube ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell-free dna (cfdna) blood collection tube market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: 5ml; 10ml
  • 2) By Sample Type: Plasma; Serum; Whole Blood
  • 3) By Application: In Vitro Diagnostics; Scientific Research
  • 4) By End-User: Diagnostic Laboratories; Hospitals Or Clinical Centers; Genetic Diagnostic Labs; Cancer Research Centers; Research And Development Institutions; Conventional Diagnostic Centers
  • Subsegments:
  • 1) By 5 mL: Single Use Tube; Vacuum Blood Collection Tube; Gel Separator Tube
  • 2) By 10 mL: Double Draw Tube; High Volume Collection Tube; Anticoagulant Treated Tube
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Becton Dickinson (BD); Qiagen N.V.; SARSTEDT AG & Co. KG; Guangzhou Improve Medical Technology; Streck Inc.; DiaCarta Inc.; Zymo Research Corporation; Biomatrica Inc.; PreAnalytiX GmbH; Beijing Cowin Bioscience Co.Ltd.; Norgen Biotek Corporation; Nonacus Limited; Guangdong Ardent Biomed Co. Ltd; MagBio Genomics Inc.; VanGenes; BEAVER; Hebei Xinle Science & Technology Co. Ltd.; Nasmed Diagnostics Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Cell-Free DNA (cfDNA) Blood Collection Tube Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Cell-Free DNA (cfDNA) Blood Collection Tube Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Enhanced Sample Preservation
    • 4.2.2 Integration With Liquid Biopsy Platforms
    • 4.2.3 Standardized Blood Collection Protocols
    • 4.2.4 Automation In Sample Processing
    • 4.2.5 High-Stability Tube Designs

5. Cell-Free DNA (cfDNA) Blood Collection Tube Market Analysis Of End Use Industries

  • 5.1 Diagnostic Laboratories
  • 5.2 Hospitals
  • 5.3 Genetic Diagnostic Labs
  • 5.4 Cancer Research Centers
  • 5.5 Research & Development Institutions

6. Cell-Free DNA (cfDNA) Blood Collection Tube Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell-Free DNA (cfDNA) Blood Collection Tube Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Cell-Free DNA (cfDNA) Blood Collection Tube PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Cell-Free DNA (cfDNA) Blood Collection Tube Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Cell-Free DNA (cfDNA) Blood Collection Tube Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell-Free DNA (cfDNA) Blood Collection Tube Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell-Free DNA (cfDNA) Blood Collection Tube Market Segmentation

  • 9.1. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 5ml, 10ml
  • 9.2. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Plasma, Serum, Whole Blood
  • 9.3. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In Vitro Diagnostics, Scientific Research
  • 9.4. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Laboratories, Hospitals Or Clinical Centers, Genetic Diagnostic Labs, Cancer Research Centers, Research And Development Institutions, Conventional Diagnostic Centers
  • 9.5. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Sub-Segmentation Of 5ml, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single Use Tube, Vacuum Blood Collection Tube, Gel Separator Tube
  • 9.6. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Sub-Segmentation Of 10ml, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Double Draw Tube, High Volume Collection Tube, Anticoagulant Treated Tube

10. Cell-Free DNA (cfDNA) Blood Collection Tube Market Regional And Country Analysis

  • 10.1. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 11.1. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 12.1. China Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 13.1. India Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 14.1. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 15.1. Australia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 16.1. Indonesia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 17.1. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 18.1. Taiwan Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 19.1. South East Asia Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 20.1. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 21.1. UK Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 22.1. Germany Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 23.1. France Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 24.1. Italy Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 25.1. Spain Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 26.1. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 27.1. Russia Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 28.1. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 29.1. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 30.1. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 31.1. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 32.1. Brazil Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 33.1. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market

  • 34.1. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Cell-Free DNA (cfDNA) Blood Collection Tube Market, Segmentation By Type, Segmentation By Sample Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell-Free DNA (cfDNA) Blood Collection Tube Market Regulatory and Investment Landscape

36. Cell-Free DNA (cfDNA) Blood Collection Tube Market Competitive Landscape And Company Profiles

  • 36.1. Cell-Free DNA (cfDNA) Blood Collection Tube Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Cell-Free DNA (cfDNA) Blood Collection Tube Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Cell-Free DNA (cfDNA) Blood Collection Tube Market Company Profiles
    • 36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Becton Dickinson (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. SARSTEDT AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis

37. Cell-Free DNA (cfDNA) Blood Collection Tube Market Other Major And Innovative Companies

  • Guangzhou Improve Medical Technology, Streck Inc., DiaCarta Inc., Zymo Research Corporation, Biomatrica Inc., PreAnalytiX GmbH, Beijing Cowin Bioscience Co.Ltd., Norgen Biotek Corporation, Nonacus Limited, Guangdong Ardent Biomed Co. Ltd, MagBio Genomics Inc., VanGenes, BEAVER, Hebei Xinle Science & Technology Co. Ltd., Nasmed Diagnostics Pvt. Ltd.

38. Global Cell-Free DNA (cfDNA) Blood Collection Tube Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Blood Collection Tube Market

40. Cell-Free DNA (cfDNA) Blood Collection Tube Market High Potential Countries, Segments and Strategies

  • 40.1 Cell-Free DNA (cfDNA) Blood Collection Tube Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Cell-Free DNA (cfDNA) Blood Collection Tube Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Cell-Free DNA (cfDNA) Blood Collection Tube Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer